Back to News
Market Impact: 0.25

BMO initiates Klarna stock coverage at Market Perform, $16 target By Investing.com

KLAREBAY
Analyst InsightsFintechCompany FundamentalsIPOs & SPACsCredit & Bond MarketsLegal & LitigationAntitrust & CompetitionProduct Launches
BMO initiates Klarna stock coverage at Market Perform, $16 target By Investing.com

BMO Capital initiated coverage on Klarna with a Market Perform rating and a $16 price target, about 10% above the current $14.55 share price. The firm called Klarna a long-term share gainer but flagged higher earnings volatility and credit risk as it leans into longer-duration credit products. Separately, Klarna reported 75% growth in in-app resell listings over 13 months and continues expanding partnerships and market reach, while its antitrust case against Google has been delayed until June 2026.

Analysis

The setup is less about a near-term re-rating and more about whether Klarna can convert brand strength into durable take-rate expansion without drifting into a lower-quality lender model. The market is likely underappreciating that longer-duration credit can look accretive in gross merchandise terms while still compressing the equity story if loss rates or funding spreads reprice even modestly; for a post-IPO financial, a 50-100 bps move in credit losses can overwhelm multiple expansion. The key second-order effect is that this becomes a balance-sheet trust trade, not just a BNPL growth trade. Competitive dynamics are favorable at the margin because embedded checkout and merchant partnerships create distribution inertia, but the more interesting winner may be marketplace rails such as eBay: a resale flow that starts inside a payments app increases transaction frequency and can deepen user retention without requiring incremental acquisition spend. That said, the monetization of adjacent products is only valuable if the company can avoid training users to treat Klarna as a generic credit wallet, which would make pricing power less sticky over time. The contrarian view is that the stock may already discount a lot of bad news after the drawdown, so upside from here likely needs either visible credit stabilization or a cleaner proof point that newer product categories improve revenue per user without deteriorating cohort behavior. Litigation delay is a noise item for the next several quarters, but the real catalyst stack is 1) quarterly credit metrics, 2) funding cost trend, and 3) evidence that non-core partnerships lift frequency faster than risk. If those data points disappoint, the equity could re-rate lower quickly because financials with uncertain asset quality tend to derate before earnings revisions catch up.